| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/05/2009 | CN101496849A Chinese medicine preparation for treating atrophic arthritis |
| 08/05/2009 | CN101496841A Chinese medicinal composition for promoting bone fracture healing and preparation method thereof |
| 08/05/2009 | CN101496838A Chinese medicament preparation for treating hyperosteogeny and rheumatism and preparation method thereof |
| 08/05/2009 | CN101496834A Preparation method of mulberry twig flavone and diphenyl ethylene extract |
| 08/05/2009 | CN101496833A Liquid external preparation for preparing total alkaloids in nux vomica |
| 08/05/2009 | CN101496826A Medicament for stretching channel, activating collaterals, compensating deficiency and invigorating yang |
| 08/05/2009 | CN101496691A Health care pillow |
| 08/05/2009 | CN101496576A Special diet and foodstuffs formula containing small peptide for patient with bone fracture |
| 08/05/2009 | CN101496575A Special nutrient foodstuffs formula containing small peptide and probiotics |
| 08/05/2009 | CN100523198C Method for detection of leptin receptor ligands |
| 08/05/2009 | CN100523187C Modified chimeric polyeptides with improved pharmacokinetic properties |
| 08/05/2009 | CN100522984C Steroid compounds having contraceptive and anti-osteoporosis activity |
| 08/05/2009 | CN100522967C Phosphorus-containing compounds & uses thereof |
| 08/05/2009 | CN100522954C Kappa-opioid receptor agonist composed of 2-phenylbenzothiazoline derivative |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522943C Vitamin d analogues |
| 08/05/2009 | CN100522248C Stable liquid compound fibrillarin blocking agent, and its preparation and use |
| 08/05/2009 | CN100522231C Externally-applied bone-set plaster and its production |
| 08/05/2009 | CN100522215C Traditional Chinese medicine composition for treating traumatic injury and bone fracture |
| 08/05/2009 | CN100522213C Medicine for bone fracture |
| 08/05/2009 | CN100522200C Pills for preventing osteoproliferation and preparing method thereof |
| 08/05/2009 | CN100522177C Application of gastrodin in the medicine for treating rheumatoid arthritis |
| 08/05/2009 | CN100522164C Method of treating of demyelinating diseases or conditions |
| 08/05/2009 | CN100522158C Application of Gulunbin, iso-gulunbin and fibleucin for preparing medicine for treating arthritis |
| 08/05/2009 | CN100522129C Skin support factors |
| 08/05/2009 | CN100521972C Composition for promotion of bone growth and maintenance of bone health |
| 08/04/2009 | US7569665 Comprises von willebrand factor a-related protein for use as diagnostic toll in diagnosis of autoimmune, arthritic and bone disorders |
| 08/04/2009 | US7569571 Such as N-cyclopropyl-4-methyl-3-(4-phenyl-pyrazolo[3,4-d]pyrimidin-1-yl)-benzamide; for inhibiting p38 kinase mediated diseases and disorders such as inflammatory diseases |
| 08/04/2009 | US7569569 Pyrrolo[2,3-d]pyrimidine compounds |
| 08/04/2009 | US7569567 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 08/04/2009 | US7569387 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 08/04/2009 | US7569364 Anti-NGF antibodies and methods using same |
| 08/04/2009 | US7569227 Monomeric protein of the TGF-β family |
| 08/04/2009 | CA2433785C Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/04/2009 | CA2406057C Methods and compositions for modulating alpha adrenergic receptor activity |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 07/30/2009 | WO2009094157A1 Dihydro- 1h- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as s1p1 agonists |
| 07/30/2009 | WO2009093584A1 Plant-origin drug for preventing or improving hyperuricemia |
| 07/30/2009 | WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof |
| 07/30/2009 | WO2009050228A3 Csf-1r inhibitors for treatment of cancer and bone diseases |
| 07/30/2009 | WO2009047361A3 Injectable fibrin compositions for tissue augmentation comprising strontium salt |
| 07/30/2009 | WO2008087560A9 Thiazolidine derivatives and methods for the preparation thereof |
| 07/30/2009 | WO2008051496A8 Use of il-1 antagonists to treat gout and pseudogout |
| 07/30/2009 | WO2007112682A8 Recombinant human parathyroid hormone-related proteins and uses thereof |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/30/2009 | US20090192201 Composition and method for treating and preventing musculoskeletal and connective tissue disorders |
| 07/30/2009 | US20090192191 Substituted hydroxamic acid derivatives as tnf inhibitors |
| 07/30/2009 | US20090192170 N-((S)-1-cyclopentyl-2-oxo-2-((3aS,6aR)-3-oxodihydro-2H-furo[3,2-b]pyrrol-4(5H,6H,6aH)-yl)ethyl)-4-(4-methylpiperazin-1-yl)benzamide; osteoporosis, Paget's disease, Chagas's, malaria, gingival diseases, hypercalcemia, metabolic bone disease, bone cancer and associated pain |
| 07/30/2009 | US20090192154 Sultam derivatives |
| 07/30/2009 | US20090192150 protease-activated receptor 1 (PAR1) inhibitors such as 1-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-(3-iminoimidazo[1,5-a]pyridin-2-yl)ethanone, used as anticoagulants |
| 07/30/2009 | US20090192133 Treatment for achondroplasia |
| 07/30/2009 | US20090192132 Pharmaceutical Composition |
| 07/30/2009 | US20090192131 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 07/30/2009 | US20090192109 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Kremen and/or Wnt |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090191640 Methods of Screening for Atherosclerosis |
| 07/30/2009 | US20090191282 Controlled release composition containing a strontium salt |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | CA2711887A1 Dihydro-1h-pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as s1p1 agonists |
| 07/30/2009 | CA2711576A1 Tricyclic compounds as modulators of tnf-.alpha. synthesis and as pde4 inhibitors |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2082754A1 Bone defect filler, release-controlled carrier, and their production methods |
| 07/29/2009 | EP2081888A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 07/29/2009 | EP2081570A2 Anti-resorptive and bone building dietary supplements and methods of use |
| 07/29/2009 | EP1989200B1 [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases |
| 07/29/2009 | EP1686119B1 Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors |
| 07/29/2009 | EP1406608B1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 07/29/2009 | EP1363876B1 Glucocorticoid receptor modulators |
| 07/29/2009 | EP1261601B1 Substituted indoles for modulating nfkb activity |
| 07/29/2009 | CN101491520A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 07/29/2009 | CN100519584C Antibodies against fibroblast growth factor 23 |
| 07/29/2009 | CN100519554C CCR5 antagonists for treating aids |
| 07/29/2009 | CN100519552C Pyrazole compounds |
| 07/29/2009 | CN100519549C Pyrimidine derivatives and pharmaceutical compositions containing the compounds |
| 07/29/2009 | CN100519539C N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100518819C Medical components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
| 07/29/2009 | CN100518779C Skeleton glue and its preparation method |
| 07/29/2009 | CN100518752C Capsule for alleviating pains of neck, shoulder waist and leg |
| 07/29/2009 | CN100518747C Matrix metalloprotease inhibitor |
| 07/28/2009 | US7566781 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 07/28/2009 | US7566767 Synthetic peptides and methods of use for autoimmune disease therapies |
| 07/28/2009 | US7566742 phosphoprotein preparation comprises a partially cross-linked partial hydrolysate of casein; a source of calcium ions; and a source of phosphate ions, or a source of strontium ions; calcium phosphate |
| 07/28/2009 | US7566741 Methods of inhibiting osteoclast activity |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566721 Substituted thienol[2,3-d]pyrimidines as kinase inhibitors |
| 07/28/2009 | US7566712 Biaryl piperazinyl-pyridine analogues |
| 07/28/2009 | US7566707 For example, 2-[3-(Tert-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-5-[(dibenzo[b,f][1,4]-oxazepin-11-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibiting effect on activity of the enzyme dipeptidylpeptidase-IV; use in treatment of diabetes mellitus, arthritis, obesity |
| 07/28/2009 | US7566699 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 07/28/2009 | US7566694 Anti-pathogen treatments |
| 07/28/2009 | US7566566 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 07/23/2009 | WO2009091905A1 Methods of treating bone-loss disorders using a gm-csf antagonist |
| 07/23/2009 | WO2009089680A1 Method of modulating membrane potential of a cell |
| 07/23/2009 | WO2009072119A3 Amphiphilic peptide matrices for treatment of osteoporosis |
| 07/23/2009 | WO2009027803A3 Polymorphs of (3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)- phenoxy)-acetic acid, free acid |
| 07/23/2009 | WO2009026158A3 Inflammation-regulating compositions and methods |
| 07/23/2009 | WO2009001214A3 Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists |
| 07/23/2009 | WO2008125901A8 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof |
| 07/23/2009 | WO2007143146A3 Method of treating inflammatory diseases using tyroskine kinase inhibitors |
| 07/23/2009 | WO2007126363A8 Antisecretory protein for use in the treatment of compartment syndrome |